Grander Acquisition

Grander Acquisition LLC, headquartered in Salt Lake City, Utah, is a biotechnology company that develops regenerative tissue products. The first regenerative tissue product from Grander Acquisition LLC is SkinTE®. SkinTE® is an innovative product designed to assist in the treatment of chronic skin ulcers. Grander Acquisition LLC has submitted an Investigational New Drug (IND) application for SkinTE® to the U.S. Food and Drug Administration (FDA) and is currently conducting two pivotal studies on SkinTE® to support a Biologics License Application (BLA) for its use in treating chronic skin ulcers. SkinTE® is currently available for investigational use only.